首页>
外国专利>
COMPOUND TARGETING FOLATE RECEPTOR OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND COMPOSITION FOR PREVENTING, DIAGNOSING, OR TREATING CANCER CONTAINING SAME AS ACTIVE INGREDIENT
COMPOUND TARGETING FOLATE RECEPTOR OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND COMPOSITION FOR PREVENTING, DIAGNOSING, OR TREATING CANCER CONTAINING SAME AS ACTIVE INGREDIENT
展开▼
机译:复合目标叶酸受体或其药学上可接受的盐及其组成,以预防,诊断或治疗包含有效成分的癌症
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention relates to a compound targeting a folate receptor or a pharmaceutically acceptable salt thereof. The present invention further relates to a composition for preventing, diagnosing, or treating cancer, containing the same as an active ingredient. According to the compound or the salt thereof, a peptide with an amino acid sequence represented by glycine-glycine-cysteine-glutamate (GGCE) is attached to folate, leading to a specific binding to a cancer cell on which folate receptors are over-expressed. Thus, the compound or the salt thereof can be useful for preventing, diagnosing, or treating cancer.;COPYRIGHT KIPO 2016
展开▼